Format

Send to

Choose Destination
Oncotarget. 2018 Dec 7;9(96):36824-36825. doi: 10.18632/oncotarget.26411. eCollection 2018 Dec 7.

How I treat rituximab refractory patients with WM.

Author information

1
Department of Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

KEYWORDS:

MYD88; Waldenstrom Macroglobulinemia; ibrutinib; refractory; rituximab

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center